| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:5-8.)
© 2007 American Heart Association, Inc.
Editorial |
From the Heart and Stroke/Richard Lewar Centre of Excellence, and Toronto General Research Institute, University Health Network, Toronto, Canada (Y.M., M.O., P.P.L.); the Hospital for Sick Children Research Institute, University of Toronto, Toronto, Canada (M.A.O.); and the Institute of Circulatory and Respiratory Health, Canadian Institutes of Health Research, Toronto and Ottawa, Canada (P.P.L.).
Correspondence to Peter Liu, MD, Institute of Circulatory and Respiratory Health, CIHR, NCSB 111266, Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, M5G 2C4, Canada. E-mail peter.liu@utoronto.ca
Key Words: Editorials myocarditis heart failure cardiomyopathy immune system inflammation
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Myocarditis classically refers to inflammation of the heart muscle. The mechanisms include host immune dysregulation and viral triggers such as coxsackievirus (CVB), adenovirus, parvovirus, and hepatitis C virus. The pathophysiology is initiated by viral proliferation in a susceptible host, inducing host immune response. The latter, when exuberant, leads to myocyte destruction and dilated cardiomyopathy.1,2 Clinically, patients with viral myocarditis will spontaneously recover in one third of cases, persist with the disease in one third, and deteriorate in another third of the cases.
Article p 94
Recent biopsy series in patients with dilated cardiomyopathy have revealed an interesting situation in which patients with symptoms of heart failure may show the presence of the viral genome alone, without any evidence of an overt inflammatory process.3 This raises the question of whether the virus can be directly responsible for the cardiomyopathy or whether it is merely an incidental bystander.
Viruses are exquisitely designed nanoparticles packaged with just the critical amount of genetic material to allow them to adapt to changing host and environmental conditions and to pass on genetic material to progeny. CVBs are single-stranded RNA viruses that have natural tropism for gut epithelial cells, immune cells, neurons, and cardiomyocytes. All strains of CVBs use the coxsackieadenoviral receptor protein to gain entry into host cells (Figure).4 The coxsackieadenoviral receptor molecule is a critical tight-junction protein important for cellcell communication and for maintenance of cell membrane integrity. Interestingly, viruses such as CVB must use host signaling mechanisms, including tyrosine kinases such as
This article has been cited by other articles:
![]() |
S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Comar, P D'Agaro, C Campello, A Poli, J P Breinholt III, J A Towbin, and M Vatta Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease J. Clin. Pathol., January 1, 2009; 62(1): 80 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dennert, H. J. Crijns, and S. Heymans Acute viral myocarditis Eur. Heart J., September 1, 2008; 29(17): 2073 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Heymans Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools Eur. Heart J., June 1, 2007; 28(11): 1279 - 1280. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |